Remarkably, TNF inhibitor-naïve patients had better treatment outcomes concerning Assessment of SpondyloArthritis International Society 20/40 response, partial remission, and Bath Ankylosing Spondylitis Disease Activity Index 20/50. The gene discussed is TNF; the disease is ankylosing spondylitis.